title: New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia.
abstract: There is now growing interest in the functional role of adenosine A2A receptors. Their distribution within the brain is restricted in the basal ganglia, particularly abundant in the striatum, which are thought to play a crucial role in the control of motor behavior. Indeed, newly developed A2A receptor selective antagonists have a profound influence on motor functions, with anti-Parkinsonian activities in several animal models. Striatal spiny neurons serve as a major anatomical locus for the relay of cortical information flow through the basal ganglia. The GABA releasing projection neurons represent the A2A receptor-mediated main target of adenosine. The GABAergic synaptic neurotransmission is regulated by adenosine via A2A receptors on the presynaptic terminals. Blockade of this modulatory function by A2A antagonists could repair striatopallidal abnormal neuronal activities provoked by striatal dopamine depletion in the Parkinsonian state. A2A receptor antagonists provide a novel therapeutic potential for the treatment of Parkinson's disease.
authors.affiliation: Pharmaceutical Research & Development Division, Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan. hiroshi.kase@kyowa.co.jp
authors.forename: H
authors.initials: H
authors.lastname: Kase
mesh_terms: D000241:Adenosine / Q000502:physiology; D000818:Animals; D001479:Basal Ganglia / Q000502:physiology* / Q000503:physiopathology; D006801:Humans; D008959:Models, Neurological; D018377:Neurotransmitter Agents / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000188:drug therapy / Q000503:physiopathology; D058915:Purinergic P1 Receptor Antagonists; D043705:Receptor, Adenosine A2A; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology
chemical_list: D018377:Neurotransmitter Agents; D058915:Purinergic P1 Receptor Antagonists; D043705:Receptor, Adenosine A2A; D018047:Receptors, Purinergic P1; D005680:gamma-Aminobutyric Acid; D000241:Adenosine